Risedronate Sodium — CAS 161735-79-1

Risedronate Sodium is a high-purity Active Pharmaceutical Ingredient (API) classified as a Bisphosphonate and Bone Resorption Inhibitor. Mediocon Inc manufactures GMP-compliant Risedronate Sodium at its facility in Aurangabad, Maharashtra, India.

• Osteoporosis treatment and prevention in postmenopausal women
• Paget's disease of bone
• Glucocorticoid-induced osteoporosis
• Osteoclast-mediated bone resorption inhibition

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support